Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.80 |
| ▸ | DGKA | P23743 | 1/20 | 0.79 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.74 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.74 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.74 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.74 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.74 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.74 |
| ▸ | CES2 | O00748 | 1/20 | 0.74 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.74 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.63 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.63 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.63 |
| ▸ | PRKCA | P17252 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19564920 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL30902502 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL19564918 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL19570300 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL24625047 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL19564924 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL25359256 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL21436112 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL21436111 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 | |
| SCHEMBL31469146 | 1.00 | FAAH (0.80) | FAAHDGKALPAR1LPAR4LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4239331-B1 | A METHOD OF PROCESSING A BIOLOGICAL SAMPLE | METABOLOMIC DIAGNOSTICS LTD (IE) | 2025-11-05 | — | — | EP | claimed |
| EP-4477092-A2 | USE OF 4-HYDROXYACETOPHENONE TO STABILIZE TASTE AND ODOR | Symrise AG (DE) | 2024-12-18 | — | — | EP | claimed |
| US-11744818-B2 | Application of trans-1,3-dilinolein in the preparation of medicaments for treating gastric cancer, stomachic tonic, health products and foods | LANZHOU UNIVERSITY (CN) | 2023-09-05 | — | — | US | claimed |
| CN-114689756-B | Analysis method of triglyceride positional isomer | 江南大学 | 2023-04-07 | — | — | CN | claimed |
| CN-112500288-B | Preparation method of trans-1,3-dilinolein | 兰州大学 | 2023-02-03 | — | — | CN | claimed |
| CN-115251159-A | Nutritional composition and application thereof in promoting growth of infants | 丰益(上海)生物技术研发中心有限公司 | 2022-11-01 | — | — | CN | claimed |
| US-20220218645-A1 | Application of Trans-1,3-Dilinolein in the Preparation of Medicaments for Treating Gastric Cancer, Stomachic Tonic, Health Products and Foods | LANZHOU UNIVERSITY (CN) | 2022-07-14 | — | — | US | claimed |
| CN-112516129-B | Application of trans-1, 3-dilinolein in preparation of drugs for treating gastric cancer, drugs for invigorating stomach, health products and foods | 兰州大学 | 2022-04-29 | — | — | CN | claimed |
| CN-109554202-B | Ethanol gasoline additive and ethanol gasoline prepared from same | 云南聚中能源科技有限公司 | 2020-09-18 | — | — | CN | claimed |
| CN-109576007-B | Alcohol ether diesel oil additive and alcohol ether diesel oil prepared from same | 云南聚中能源科技有限公司 | 2020-07-31 | — | — | CN | claimed |
| US-12564198-B2 | Method for manufacturing sn-2 palmitic triacylglycerols | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-03 | — | — | US | disclosed |
| US-20260007142-A1 | FAT FORMULATIONS | Savor Foods Limited (US) | 2026-01-08 | — | — | US | disclosed |
| US-20260007141-A1 | FAT FORMULATIONS | Savor Foods Limited (US) | 2026-01-08 | — | — | US | disclosed |
| EP-4132282-B1 | METHOD FOR MANUFACTURING SN-2 PALMITIC TRIACYLGLYCEROLS | NESTLE SA (CH) | 2025-12-03 | — | — | EP | disclosed |
| EP-4239331-B1 | A METHOD OF PROCESSING A BIOLOGICAL SAMPLE | METABOLOMIC DIAGNOSTICS LTD (IE) | 2025-11-05 | — | — | EP | disclosed |
| WO-1991007168-A1 | RIBOFLAVIN AS A TANNING ENHANCER | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| WO-1991007167-A1 | PROTEIN KINASE ACTIVATORS AS ENHANCERS OF MELANIN PRODUCTION | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| EP-0285101-A1 | Novel monoglyceride lipase, its production process, and analytical method making use of same | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-10-05 | — | — | EP | disclosed |
| US-4156719-A | DRUG, NONIONIC SURFACTANT OR BILE ACID, FATTY ACID OR GLYCERIDE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1979-05-29 | — | — | US | disclosed |
| US-3988446-A | Glycerides with anti-inflammatory properties | ABBOTT LABORATORIES (US) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007141-A1 | FAT FORMULATIONS | FABP4, LIPC, SCD | FAAH 236/4885DGKA 316/4885LPAR1 526/4885 |
| US-20220218645-A1 | Application of Trans-1,3-Dilinolein in the Preparation of Medicaments for Treating Gastric Cancer, Stomachic Tonic, Health Products and Foods | HYOU1, TGOLN2, DSG1 | FAAH 2959/4885DGKA 182/4885LPAR1 1425/4885 |
| US-20260007142-A1 | FAT FORMULATIONS | FABP4, LIPC, FASN | FAAH 231/4885DGKA 68/4885LPAR1 2490/4885 |
| US-11744818-B2 | Application of trans-1,3-dilinolein in the preparation of medicaments for treating gastric cancer, stomachic tonic, health products and foods | HYOU1, TGOLN2, DSG1 | FAAH 2959/4885DGKA 182/4885LPAR1 1425/4885 |
| US-12564198-B2 | Method for manufacturing sn-2 palmitic triacylglycerols | LPL, PNLIP, MTTP | FAAH 1317/4885DGKA 993/4885LPAR1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.